Discounted Cash Flow Rating

Strong Buy

Return on Equity Rating

Strong Buy

Debt to Equity Rating

Strong Sell

Price to Earnings Rating

Neutral

Analyst Rating

Neutral

Simple Moving Average

Strong Sell

Exponential Moving Average

Strong Sell

Relative Strength Index

Neutral

Standard Deviation

Strong Buy

Williams %R

Strong Buy

Average Directional Index

Strong Sell

Insider Trading

Neutral

Wall Street Data Solutions Rating

Neutral

B

Acorda Therapeutics, Inc. (ACOR)

Biological Products, (no Disgnostic Substances)

https://www.acorda.com

Acorda Therapeutics Inc is a biopharmaceutical company engaged in developing therapies that restore function and improve the lives of people with neurological disorders. The company market Inbrija (levodopa inhalation powder), which is approved in the U.S. for intermittent treatment of OFF episodes, also known as OFF periods, in people with Parkinson's disease treated with carbidopa/levodopa. Inbrija is for as-needed use and utilizes the ARCUS pulmonary delivery system, a technology platform designed to deliver medication through inhalation. The company also markets branded Ampyra (dalfampridine) Extended-Release Tablets, 10 mg to improve walking in adults with multiple sclerosis.

TWO BLUE HILL PLAZA
PEARL RIVER, NY

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

02/10/2006

Market Cap

821,028

Shares Outstanding

1,240,000

Weighted SO

1,242,098

Total Employees

N/A

Upcoming Earnings

N/A

Similar Tickers

TAIPY --.--%

SGIOF --.--%

OASMY --.--%

PCRX --.--%

SBFMW --.--%

LSDI --.--%

BFRI --.--%

JUPW --.--%

SHPH --.--%

Beta

1.4620

Last Div

0.0000

Range

0.6116-24.2

Chg

-0.2090

Avg Vol

125680

Mkt Cap

821028

Exch

NASDAQ

Country

US

Phone

914 347 4300

DCF Diff

5.6450

DCF

6.7150

Div Yield

0.0000

P/S

0.0071

EV Multiple

541.5521

P/FV

-0.0044

Div Yield %

0.0000

P/E

-0.0031

PEG

0.0000

Payout

0.0000

Current Ratio

0.2164

Quick Ratio

0.0828

Cash Ratio

0.0418

DSO

28.9945

DIO

219.7814

Op Cycle

248.7759

DPO

154.6051

CCC

94.1708

Gross Margin

0.7973

Op Margin

-0.2101

Pretax Margin

-2.6321

Net Margin

-2.2775

Eff Tax Rate

0.1347

ROA

-3.2292

ROE

4.8580

ROCE

0.1707

NI/EBT

0.8653

EBT/EBIT

12.5294

EBIT/Rev

-0.2101

Debt Ratio

2.4017

D/E

-1.0546

LT Debt/Cap

-0.0156

Total Debt/Cap

19.3044

Int Coverage

-0.7408

CF/Debt

-0.1386

Equity Multi

-0.4391

Rec Turnover

12.5886

Pay Turnover

2.3609

Inv Turnover

1.6607

FA Turnover

19.8258

Asset Turnover

1.4179

OCF/Share

-21.8607

FCF/Share

-22.0733

Cash/Share

7.5395

OCF/Sales

-0.2347

FCF/OCF

1.0097

CF Coverage

-0.1386

ST Coverage

-0.1406

CapEx Coverage

-102.8447

Div&CapEx Cov

-102.8447

P/BV

-0.0044

P/B

-0.0044

P/S

0.0071

P/E

-0.0031

P/FCF

-0.0299

P/OCF

-0.0302

P/CF

-0.0302

PEG

0.0000

P/S

0.0071

EV Multiple

541.5521

P/FV

-0.0044

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation